Skip to content

Embecta Corp. EMBC Interest Expense

Interest Expense at other companies

Insulet logo
InsuletPODD
$14.7M+59.8%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$2.2M+18.4%
Medtronic logo
MedtronicMDT
$176M+1.1%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$3.93M+135%
ICU Medical logo
ICU MedicalICUI
$16.49M-25.1%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$149M-0.7%

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Reported directly by Embecta Corp. in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s interest expense?
Embecta Corp. (EMBC) reported interest expense of -$22.6M in Q1 2026.
How has Embecta Corp.'s interest expense changed year-over-year?
Embecta Corp.'s interest expense increased by 15.4% year-over-year, from -$26.7M to -$22.6M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.